TOMI Environmental Solutions Announces Specialized Service Provider for Healthcare and Mold Remediation

FREDERICK, Md., Sept. 24, 2025 (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc.® (“TOMI”) (NASDAQ: TOMZ), a global company specializing in disinfection and decontamination solutions, today announced a new service provider this quarter, expanding the use of its SteraMist iHP technology. This new provider has invested approximately $185,500 in SteraMist mobile systems and BIT solution, launching its operations for mold and mycotoxins remediation in the healthcare industry. The provider has since secured a major contract to remediate a 400,000-cubic-feet space at a hospital including HVAC decontamination.

"We are incredibly excited to partner with them as they make strides into the healthcare industry," said Elissa J. (E.J.) Shane, COO of TOMI Environmental Solutions. "Their leadership, which includes a prominent figure in restoration and seasoned personnel, brings unique industry and operating expertise. They have been extensively trained on our technology and are well-prepared to deliver exceptional service."

This new service provider also has a working relationship with Inc., a long-standing exclusive partner of TOMI and experts in mold remediation. Enviro-Mist Inc. continues to use SteraMist for mold remediation as well as the decontamination of pharmaceutical and life sciences facilities throughout the West Coast, including a multi-year service contract for a Pfizer facility.

TOMI™ Environmental Solutions, Inc.: Innovating for a safer world®

TOMI™ Environmental Solutions, Inc. (NASDAQ: ) is a global decontamination and infection prevention company, providing environmental solutions for disinfection through the manufacturing, sales and licensing of its premier Binary Ionization Technology® (BIT™) platform. Invented under a defense grant in association with the Defense Advanced Research Projects Agency (DARPA) of the U.S. Department of Defense, BIT™ solution utilizes a low percentage hydrogen peroxide as its only active ingredient and uses patented ionized Hydrogen Peroxide (iHP™) technology in all SteraMist systems to create superior disinfection. TOMI products are designed to service a broad spectrum of use sites, including, but not limited to, hospitals and medical facilities, biosafety labs, pharmaceutical facilities, commercial and office buildings, schools, restaurants, meat and produce processing facilities, and police and fire departments.

For additional information, please visit  or contact us at 

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995

This press release contains forward-looking statements that are based on current expectations, estimates, forecasts and projections of future performance based on management’s judgment, beliefs, current trends, and anticipated product performance. These forward-looking statements include, without limitation, statements relating to TOMI’s products to serve healthcare sectors. Forward-looking statements involve risks and uncertainties that may cause actual results to differ materially from those contained in the forward-looking statements. These factors include, but are not limited to, our ability to maintain and manage growth and generate sales, our reliance on a single or a few products for a majority of revenues; the general business and economic conditions; and other risks as described in our SEC filings, including our Annual Report on Form 10-K for the fiscal year ended December 31, 2023 filed by us with the SEC and other periodic reports we filed with the SEC. The information provided in this document is based upon the facts and circumstances known at this time. Other unknown or unpredictable factors or underlying assumptions subsequently proving to be incorrect could cause actual results to differ materially from those in the forward-looking statements. Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee future results, level of activity, performance, or achievements. You should not place undue reliance on these forward-looking statements. All information provided in this press release is as of today’s date, unless otherwise stated, and we undertake no duty to update such information, except as required under applicable law.

INVESTOR RELATIONS CONTACT:

John Nesbett/Rosalyn Christian

IMS Investor Relations